Nilutamide | Interleukin Related interleukin-related.com

Product Name :
Nilutamide

Search keywords :
Nilutamide

drugId :
null

Target Vo:
Androgen Receptor

Target Vo Short Name :
AR

Moa_Name:
Androgen Receptor antagonists

First Approval Country :
France

First Approval Date Filter:
1987

Origin Company_Name :

Active Company_Name :
Concordia

Active Indication_Name:
Prostatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Omburtamab medchemexpress
RPA70 (Y10P88) Mouse mAb Purity & Documentation
DsbA Tag Antibody (YA868): DsbA Tag Antibody (YA868) is an unconjugated, approximately 23 kDa, mouse-derived, anti-DsbA Tag (YA868) monoclonal antibody. DsbA Tag Antibody (YA868) can be used for: WB expriments in Escherichia coli background without labeling.

Author: Interleukin Related

Related Posts